DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 44 filers reported holding OBALON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$1,531,000
-48.1%
446,2840.0%0.05%
-54.3%
Q4 2017$2,950,000
-11.9%
446,284
+27.0%
0.12%
-23.2%
Q3 2017$3,348,000
+84.6%
351,284
+91.9%
0.15%
+55.7%
Q2 2017$1,814,000
+709.8%
183,086
+773.8%
0.10%
+977.8%
Q1 2017$224,00020,9530.01%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 3,552,239$9,591,0004.68%
Tamarack Advisers, LP 2,100,000$5,670,0001.62%
Moisand Fitzgerald Tamayo, LLC 6,765$302,0000.17%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$892,0000.10%
HoyleCohen, LLC 114,650$310,0000.06%
Granite Investment Partners, LLC 77,511$210,0000.01%
C WorldWide Group Holding A/S 315,504$852,0000.01%
Cerity Partners LLC 20,686$56,0000.00%
Spark Investment Management LLC 18,300$49,0000.00%
HighTower Advisors, LLC 126,288$342,0000.00%
View complete list of OBALON THERAPEUTICS INC shareholders